International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: http://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2016, 4(3), 92-94
DOI: 10.12691/ijcd-4-3-12
Open AccessArticle

Nutrients, Bugs and Us: The Short-chain Fatty Acids Story in Celiac Disease

Aaron Lerner1, 2, , Jeremias Patricia2 and Torsten Matthias2

1B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

2AESKU.KIPP Institute, Wendelsheim, Germany

Pub. Date: October 11, 2016

Cite this paper:
Aaron Lerner, Jeremias Patricia and Torsten Matthias. Nutrients, Bugs and Us: The Short-chain Fatty Acids Story in Celiac Disease. International Journal of Celiac Disease. 2016; 4(3):92-94. doi: 10.12691/ijcd-4-3-12

Abstract

The gut ecosystem with myriads of microorganisms and the high concentration of immune system cells can be considered as a separate organ on its own. The balanced interaction between the host and microbial cells has been shaped during the long co-evolutionary process. In dysbiotic conditions, however, this balance is compromised and results in abnormal interaction between the host and microbiota. Celiac disease is such an example were dysbiotic and metabolic signature are shaping the disease progression in genetically susceptible individuals. Short chain fatty acids are bacterial originated metabolic messenger between the pathobionts and the intestinal mucosa. Their local luminal effects and systemic ones were just recently unraveled. Accumulating data attribute multiple beneficial effects to them. Changes in microbiota and their short-chain fatty acids production is clearly related to the pathogenesis of celiac disease and might open new therapeutic strategies to combat the disease.

Keywords:
celiac disease stool microbiota dysbiota bacteria short-chain fatty acids

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Lerner A, Aminov R, Matthias T. Dysbiosis may trigger autoimmune diseases via inappropriate posttranslational modification of host proteins. Frontiers in Microbiology. 2016; 7: Article 84.
 
[2]  Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016; 14: 127-38.
 
[3]  Cenit MC, Olivares M, Codoñer-Franch P, Sanz Y. Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution? Nutrients. 2015; 7: 6900-23.
 
[4]  Maša Primec, Martina Klemenak, Irene Aloisio, Mario Gorenjak, Diana Di Gioia, Dušanka Mičetić-Turk, Tomaž Langerholc. Faecal Concentrations of Short-chain Fatty Acids and Selected Bacteria in Healthy and Celiac Children. Internat J of Celiac Disease. 2016; 4: 95-101.
 
[5]  Walter H. Moos, Douglas V. Faller, David N. Harpp, Iphigenia Kanara,Julie Pernokas, Whitney R. Powers, nKosta Steliou. Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access. 2016; 5: 137-145.
 
[6]  Nistal E, Caminero A, Vivas S, Ruiz de Morales JM, Sáenz de Miera LE, Rodríguez-Aparicio LB, Casqueiro J. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie. 2012; 94: 1724-9.
 
[7]  Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011; 4; 11: 219.
 
[8]  Di Cagno R, Rizzello CG, Gagliardi F, Ricciuti P, Ndagijimana M, Francavilla R, et al. Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease. Appl Environ Microbiol. 2009 ; 75: 3963-71.
 
[9]  Sun Y, O'Riordan MX. Regulation of bacterial pathogenesis by intestinal short-chain Fatty acids. Adv Appl Microbiol. 2013; 85: 93-118.
 
[10]  den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54: 2325-40.
 
[11]  Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 2015; 7: 2839-49.
 
[12]  Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond). 2015; 39: 1331-8.
 
[13]  Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014; 20: 159-66.
 
[14]  Miyamoto J, Kasubuchi M, Nakajima A, Irie J, Itoh H, Kimura I. The role of short-chain fatty acid on blood pressure regulation. Curr Opin Nephrol Hypertens. 2016; 25: 379-83.
 
[15]  Natarajan N, Pluznick JL. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol. 2014; 307: C979-85.
 
[16]  Lerner A., Matthias T. Food Industrial Microbial Transglutaminase in Celiac Disease: Treat or Trick. International J Celiac Dis. 2015; 3: 1-6.
 
[17]  Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, et al. Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access. 2016; 5: 137-45.
 
[18]  Eisenstein M. Living factories of the future. Nature. 2016; 531: 401-3.
 
[19]  Garber K. Drugging the gut microbiome. Nat Biotechnol. 2015; 33: 228-31.
 
[20]  Madhusoodanan J Viral Soldiers. The Scientist 2016; 30: 27-33.